Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Aurora Kinase a: A New Component of Imatinib Resistance in Chronic Myeloid Leukemia

Manuela Mancini, PhD, Simona Soverini, Elisa Leo, PhD, Fausto Castagnetti, PhD, Caterina De Benedittis, PhD, Gabriele Gugliotta, PhD, Gianantonio Rosti, MD, Maria Alessandra Santucci, MD, Michele Cavo, Giovanni Martinelli, MD PhD

Blood (2015) 126 (23): 1573.

https://doi.org/10.1182/blood.V126.23.1573.1573

Published: 2015

Journal Articles

FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia

Elisa Leo, PhD, Giorgia Simonetti, PhD, Manuela Mancini, PhD, Nevena Veljkovic, PhD, Virginia Campi, Fausto Castagnetti, MD, Gabriele Gugliotta, MD, Caterina De Benedittis, Maria Alessandra Santucci, MD, Giovanni Martinelli, MD

Blood (2014) 124 (21): 3125.

https://doi.org/10.1182/blood.V124.21.3125.3125

Published: 2014

Journal Articles

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

Michela Aluigi, PhD, Manuela Mancini, PhD, Elisa Leo, PhD, Fausto Castagnetti, Carmen Baldazzi, Enza Barbieri, MD, Maria Alessandra Santucci, MD

Blood (2011) 118 (21): 1676.

https://doi.org/10.1182/blood.V118.21.1676.1676

Published: 2011

Journal Articles

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

Giulia Perrone, MD, Enrica Borsi, PhD, Carolina Terragna, PhD, Sandra Durante, Marina Martello, Michela Aluigi, PhD, Manuela Mancini, PhD, Elena Zamagni, MD, Paola Tacchetti, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Beatrice Anna Zannetti, MD, Giovanni Martinelli, MD, Maria Alessandra Santucci, MD, Michele Baccarani, MD, Michele Cavo, MD

Blood (2011) 118 (21): 2901.

https://doi.org/10.1182/blood.V118.21.2901.2901

Published: 2011

Journal Articles

Apoptotic Death of Bcr-Abl-Expressing Myeloid Progenitors in Response to the m-Tor Inhibitor RAD001 (Everolimus) Is Promoted by the Nuclear Import of c-Abl.

Manuela Mancini, PhD, Elisa Zuffa, PhD, Patrizia Corrado, BS, Gianluca Brusa, PhD, Sara Petta, BS, Eleonora Pagnotta, PhD, Maria Alessandra Santucci, MD

Blood (2006) 108 (11): 2133.

https://doi.org/10.1182/blood.V108.11.2133.2133

Published: 2006

Journal Articles

P210 Tyrosine Kinase Regulates the Expression of 14-3-3sigma in Hematopoietic Progenitors Expressing the bcr-abl Fusion Gene.

Maria Alessandra Santucci, MD, Manuela Mancini, PhD, Elisa Zuffa, BS, Gianluca Brusa, PhD, Enza Barbieri, MD

Blood (2005) 106 (11): 4847.

https://doi.org/10.1182/blood.V106.11.4847.4847

Published: 2005

Journal Articles

A Novel 4-anilino-3-quinolinecarbonitrile Dual Src and Abl Kinase Inhibitor (SKI-606) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.

Tiziana Grafone, Manuela Mancini, Emanuela Ottaviani, Matteo Renzulli, Frank Boschelli, Laura Ferraretti, Maria Alessandra Santucci, Marilina Amabile, Simona Soverini, Carolina Terragna, Angela Poerio, Gianantonio Rosti, Cristian Taccioli, Michele Baccarani, Giovanni Martinelli

Blood (2004) 104 (11): 1991.

https://doi.org/10.1182/blood.V104.11.1991.1991

Published: 2004

NARROW

Aurora Kinase a: A New Component of Imatinib Resistance in Chronic Myeloid Leukemia

FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

Apoptotic Death of Bcr-Abl-Expressing Myeloid Progenitors in Response to the m-Tor Inhibitor RAD001 (Everolimus) Is Promoted by the Nuclear Import of c-Abl.

P210 Tyrosine Kinase Regulates the Expression of 14-3-3sigma in Hematopoietic Progenitors Expressing the bcr-abl Fusion Gene.

A Novel 4-anilino-3-quinolinecarbonitrile Dual Src and Abl Kinase Inhibitor (SKI-606) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.

Email alerts

ASH Publications

American Society of Hematology

Aurora Kinase a: A New Component of Imatinib Resistance in Chronic Myeloid Leukemia

FOXM1 Transcription Factor Is a Component of Beta Catenin Signaling in Hematopoietic Progenitors of Chronic Myeloid Leukemia

C22 orf2 Gene (22q13.1) Translocation Downstream of Bcr Breakpoint (22q11) to the Derivative 9 Chromosome Is Associated with Reduced Expression of Its Protein, the Beta-Catenin Antagonist Chibby, in Chronic Myeloid Leukemia Progenitors

HIF 1 Alpha: A Suitable Target for Multiple Myeloma

Apoptotic Death of Bcr-Abl-Expressing Myeloid Progenitors in Response to the m-Tor Inhibitor RAD001 (Everolimus) Is Promoted by the Nuclear Import of c-Abl.

P210 Tyrosine Kinase Regulates the Expression of 14-3-3sigma in Hematopoietic Progenitors Expressing the bcr-abl Fusion Gene.

A Novel 4-anilino-3-quinolinecarbonitrile Dual Src and Abl Kinase Inhibitor (SKI-606) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only